Press release
Disease Management Apps Market Report 2024 - Disease Management Apps Market Trends And Share
Disease Management Apps Market
According to The Business Research Company's, The disease management apps market size has grown rapidly in recent years. It will grow from $10.17 billion in 2023 to $11.55 billion in 2024 at a compound annual growth rate (CAGR) of 13.6%. The growth in the historic period can be attributed to infrastructure development boom, mining and quarrying activities, agricultural mechanization, government infrastructure investment, global economic growth.
The disease management apps market size is expected to see rapid growth in the next few years. It will grow to $18.96 billion in 2028 at a compound annual growth rate (CAGR) of 13.2%. The growth in the forecast period can be attributed to renewable energy projects, focus on sustainable construction practices, e-commerce infrastructure development, rise in disaster response and recovery efforts, global urban population growth. Major trends in the forecast period include enhancement of operator comfort and safety, application of advanced materials for durability, integration of intelligent machine control systems, focus on modular and versatile attachments, implementation of predictive maintenance technologies, adoption of remote control and teleoperation..
Get The Complete Scope Of The Report @
https://www.thebusinessresearchcompany.com/report/disease-management-apps-global-market-report
Market Drivers and Trends:
The increasing prevalence of chronic disorders is expected to propel the growth of the disease management apps market going forward. Chronic conditions also known as chronic diseases refer to long-lasting medical conditions that persist over an extended period, typically for three months or more. Disease management apps are in chronic diseases for providing tools to track symptoms, log medication intake, monitor vital signs, and identify triggers. For instance, in September 2022, according to the World Health Organization (WHO), a Switzerland-based specialized agency of the United Nations, there were 41 million deaths, which is 74% of those caused by chronic diseases every year across the globe. There were 17.9 million deaths from cardiovascular diseases, 9.3 million deaths from cancer, 4.1 million deaths from chronic respiratory diseases, and 2.0 million deaths from diabetes. Therefore, the increasing prevalence of chronic conditions is driving the growth of the disease management apps market going forward.
Major companies operating in the disease management apps market are focusing on technological advancements such as GenAI to increase their profitability in the market. GenAI is an artificial intelligence technology that enables the automation of clinical summary report generation and enhances communication between patients and providers. For instance, in August 2023, Huma Therapeutics, a UK-based healthcare technology company, launched the GenAI artificial intelligence (AI) disease management platform technology using Google Cloud. This latest technology is specifically designed to integrate into its disease-management platform to improve the decision-making tools for diagnostic treatment and recommendations.
Key Benefits for Stakeholders:
• Comprehensive Market Insights: Stakeholders gain access to detailed market statistics, trends, and analyses that help them understand the current and future landscape of their industry.
• Informed Decision-Making: The reports provide crucial data that support strategic decisions, reducing risks and enhancing business planning.
• Competitive Advantage: With in-depth competitor analysis and market share information, stakeholders can identify opportunities to outperform their competition.
• Tailored Solutions: The Business Research Company offers customized reports that address specific needs, ensuring stakeholders receive relevant and actionable insights.
• Global Perspective: The reports cover various regions and markets, providing a broad view that helps stakeholders expand and operate successfully on a global scale.
Ready to Dive into Something Exciting? Get Your Free Exclusive Sample of Our Research Report @
https://www.thebusinessresearchcompany.com/sample.aspx?id=13426&type=smp
Major Key Players of the Market:
Alphabet Inc., International Business Machines Corporation, Siemens Healthineers AG, Koninklijke Philips N.V. , Garmin International Inc., DexCom Inc., Epic Systems Corporation, Teladoc Inc. , Fitbit LLC, athenahealth Inc., Allscripts Healthcare Solutions Inc., Omada Health Inc., Calm.com Inc., Livongo Health Inc., American Well Corporation, MyFitnessPal Inc., Talkspace Inc., Noom Inc., Ada Health GmbH, Healthy.io.Ltd., Medisafe International LLC, Sleep Cycle AB, Buoy Health Inc., Azumio Inc., Propeller Health Inc., Welldoc Inc., Informed Data Systems Inc., Curable Inc.
Disease Management Apps Market 2024 Key Insights:
• The Disease Management Apps Market is expected to grow to $18.96 billion in 2028 at a compound annual growth rate (CAGR) of 13.2%.
• Chronic Condition Prevalence Fuels The Expansion Of The Disease Management Apps Market
• Companies Harness Genai For Enhanced Profitability In The Disease Management Apps Market
• North America was the largest region in the disease management apps market in 2023.
We Offer Customized Report, Click @
https://www.thebusinessresearchcompany.com/customise?id=13426&type=smp
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ"
Learn More About The Business Research Company
The Business Research Company (www.thebusinessresearchcompany.com) is a leading market intelligence firm renowned for its expertise in company, market, and consumer research. With a global presence, TBRC's consultants specialize in diverse industries such as manufacturing, healthcare, financial services, chemicals, and technology, providing unparalleled insights and strategic guidance to clients worldwide.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Disease Management Apps Market Report 2024 - Disease Management Apps Market Trends And Share here
News-ID: 3678831 • Views: …
More Releases from The Business research company
C-X-C Chemokine Receptor Type 2 Market on Track for Strong Growth, Estimated to …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Is the Expected CAGR for the C-X-C Chemokine Receptor Type 2 Market Through 2025?
There has been a significant expansion in the market for C-X-C chemokine receptor type 2 in the past few years. The market is projected to increase from $1.24 billion in 2024 to $1.38 billion…
Top Market Shifts Transforming the Coenzyme Q10 Market Landscape: Key Insights
"Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Is the Expected CAGR for the Coenzyme Q10 Market Through 2025?
The market size of coenzyme Q10 has seen impressive expansion in the past years, with predictions stating an increase from $0.74 billion in 2024 up to $0.84 billion in 2025, implying a compound annual growth rate (CAGR)…
2025-2034 Chimeric Antibody Market Evolution: Disruptions, Innovations, and Unta …
"Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Is the Expected CAGR for the Chimeric Antibody Market Through 2025?
In recent times, there has been a swift expansion in the chimeric antibody market size. We can expect an increase from $12.27 billion in 2024 to $13.74 billion in 2025, reflecting a compound annual growth rate (CAGR)…
2025-2034 Chimeric Antibody Market Evolution: Disruptions, Innovations, and Unta …
"Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Is the Expected CAGR for the Chimeric Antibody Market Through 2025?
In recent times, there has been a swift expansion in the chimeric antibody market size. We can expect an increase from $12.27 billion in 2024 to $13.74 billion in 2025, reflecting a compound annual growth rate (CAGR)…
More Releases for Disease
Protheragen Announces Disease Model Development Services to Enhance Rare Disease …
Protheragen announced the release of its disease model development services provided to enhance rare disease research. With an increasing focus on rare diseases and the need for tailored research models, Protheragen is dedicated to providing cutting-edge solutions to support this important area of medical research.
Rare diseases, which affect a small percentage of the population, pose unique challenges for researchers due to their limited understanding and lack of available treatment options.…
Biopharmaceutical Fermentation Market 2022 | Growing Morbidity of Genetic Diseas …
According to Precision Business Insights (PBI), the latest report, the biopharmaceutical fermentation market is expected to be valued at USD 10,302.1 million in 2022, growing at a 4.7% CAGR from 2022 to 2028. The growing prevalence of chronic illness, cancer, cardiac diseases, infectious diseases, antibiotic resistance, autoimmune diseases, etc., globally causes the leaning toward biopharmaceutical products, which show promising results in the research studies. Moreover, new findings by the…
Global Inflammatory Bowel Disease (IBD) Market Key Players Analysis, Disease Ind …
Global Inflammatory Bowel Disease (IBD) Market, valued at USD 210.5 Billion in the year 2020 has been driven by factors such as the increasing prevalence of Ulcerative Colitis and Crohn’s Disease, advances in medical technology, government support for inflammatory bowel disease treatment research, and the ubiquity of anxiety and depression. Moreover, factors such as the irregular food habits, unhealthy lifestyle of people, increased level of pollution and increase in alcohol…
Moyamoya Disease Market - A Scientometric Assessment of Disease During 2018-23
Market Highlight:
Moyamoya disease (MMD) is a chronic, cerebrovascular disease characterized by progressive stenosis in the internal carotid artery and an abnormal vascular network at the base of the brain. The stroke is one of the significant symptoms of moyamoya disease, which further leads to paralysis of the face, arms, and legs, loss of speech, and temporary loss of neurologic function of body parts, visual disturbances, headaches, developmental delay, and…
Refsum Disease Industry An Overview of A New Disease - 2018
"Refsum Disease" is a genetic disorder which is inherited as an autosomal recessive trait. The condition is characterized by progressive loss of vision (retinitis pigmentosa), failure of muscle coordination (ataxia), degenerative nerve disease (peripheral neuropathy), and dry, rough, scaly skin (ichthyosis). The accumulation of fatty acid (phytanic acid) in blood plasma and tissues is the main cause of refsum disease. This occurs due to malfunction of the enzyme producing gene…
Chagas Disease (Infectious Disease) Pipeline Forecast Report, H1, 2017 [MRH]
Market Research Hub's Pharmaceutical and Healthcare latest pipeline guide Chagas Disease - Pipeline Review, H1 2017, provides comprehensive information on the therapeutics under development for Chagas Disease Market (Infectious Disease), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and…
